Annual Retained Earnings
-$289.88 M
-$29.20 M-11.20%
December 31, 2023
Summary
- As of March 10, 2025, OCX annual retained earnings is -$289.88 million, with the most recent change of -$29.20 million (-11.20%) on December 31, 2023.
- During the last 3 years, OCX annual retained earnings has fallen by -$166.20 million (-134.38%).
- OCX annual retained earnings is now -2683.79% below its all-time high of -$10.41 million, reached on December 31, 2013.
Performance
OCX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$317.03 M
-$13.49 M-4.45%
September 30, 2024
Summary
- As of March 10, 2025, OCX quarterly retained earnings is -$317.03 million, with the most recent change of -$13.49 million (-4.45%) on September 30, 2024.
- Over the past year, OCX quarterly retained earnings has stayed the same.
- OCX quarterly retained earnings is now -1958.76% below its all-time high of -$15.40 million, reached on December 31, 2014.
Performance
OCX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
OCX Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -11.2% | 0.0% |
3 y3 years | -134.4% | -53.6% |
5 y5 years | -306.4% | -53.6% |
OCX Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -54.4% | at low | -68.8% | at low |
5 y | 5-year | -209.2% | at low | -238.2% | at low |
alltime | all time | -2683.8% | at low | -1958.8% | at low |
OncoCyte Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$317.03 M(+4.4%) |
Jun 2024 | - | -$303.54 M(+1.5%) |
Mar 2024 | - | -$299.00 M(+3.1%) |
Dec 2023 | -$289.88 M(+11.2%) | -$289.88 M(+6.4%) |
Sep 2023 | - | -$272.46 M(+2.4%) |
Jun 2023 | - | -$265.98 M(+3.2%) |
Mar 2023 | - | -$257.64 M(-1.2%) |
Dec 2022 | -$260.68 M(+38.8%) | -$260.68 M(+20.9%) |
Sep 2022 | - | -$215.70 M(+4.5%) |
Jun 2022 | - | -$206.44 M(+4.2%) |
Mar 2022 | - | -$198.06 M(+5.5%) |
Dec 2021 | -$187.77 M(+51.8%) | -$187.77 M(+23.6%) |
Sep 2021 | - | -$151.89 M(+10.0%) |
Jun 2021 | - | -$138.09 M(+8.2%) |
Mar 2021 | - | -$127.60 M(+3.2%) |
Dec 2020 | -$123.68 M(+31.9%) | -$123.68 M(+5.4%) |
Sep 2020 | - | -$117.37 M(+6.1%) |
Jun 2020 | - | -$110.58 M(+9.0%) |
Mar 2020 | - | -$101.48 M(+8.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2019 | -$93.75 M(+31.4%) | -$93.75 M(+9.3%) |
Sep 2019 | - | -$85.79 M(+6.5%) |
Jun 2019 | - | -$80.57 M(+7.2%) |
Mar 2019 | - | -$75.18 M(+5.4%) |
Dec 2018 | -$71.32 M(+30.4%) | -$71.32 M(+6.7%) |
Sep 2018 | - | -$66.82 M(+4.7%) |
Jun 2018 | - | -$63.85 M(+7.6%) |
Mar 2018 | - | -$59.34 M(+8.5%) |
Dec 2017 | -$54.68 M(+54.9%) | -$54.68 M(+7.8%) |
Sep 2017 | - | -$50.72 M(+15.8%) |
Jun 2017 | - | -$43.81 M(+9.5%) |
Mar 2017 | - | -$40.01 M(+13.3%) |
Dec 2016 | -$35.30 M(+46.3%) | -$35.30 M(+9.6%) |
Sep 2016 | - | -$32.20 M(+8.8%) |
Jun 2016 | - | -$29.61 M(+9.4%) |
Mar 2016 | - | -$27.06 M(+12.1%) |
Dec 2015 | -$24.13 M(+56.7%) | -$24.13 M(+17.2%) |
Sep 2015 | - | -$20.59 M(+33.7%) |
Dec 2014 | -$15.40 M(+47.9%) | -$15.40 M |
Dec 2013 | -$10.41 M | - |
FAQ
- What is OncoCyte annual retained earnings?
- What is the all time high annual retained earnings for OncoCyte?
- What is OncoCyte annual retained earnings year-on-year change?
- What is OncoCyte quarterly retained earnings?
- What is the all time high quarterly retained earnings for OncoCyte?
- What is OncoCyte quarterly retained earnings year-on-year change?
What is OncoCyte annual retained earnings?
The current annual retained earnings of OCX is -$289.88 M
What is the all time high annual retained earnings for OncoCyte?
OncoCyte all-time high annual retained earnings is -$10.41 M
What is OncoCyte annual retained earnings year-on-year change?
Over the past year, OCX annual retained earnings has changed by -$29.20 M (-11.20%)
What is OncoCyte quarterly retained earnings?
The current quarterly retained earnings of OCX is -$317.03 M
What is the all time high quarterly retained earnings for OncoCyte?
OncoCyte all-time high quarterly retained earnings is -$15.40 M
What is OncoCyte quarterly retained earnings year-on-year change?
Over the past year, OCX quarterly retained earnings has changed by $0.00 (0.00%)